A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729

Clinical trial NCT01813084 · COMPLETED

Trial details

NCT number: NCT01813084
Sponsor: Respivert Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Healthy Volunteers

Start date: 2013-05-01
Primary completion: 2014-04-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.